Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Tilman (Cambridge, United Kingdom), E. Koutsouraki (Cambridge, United Kingdom), S. Humphreys (Cambridge, United Kingdom), A. Barnes (Cambridge, United Kingdom). Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research. 2343

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract -  Effect of Hypercapnia in human primary culture of alveolar cells in vitro Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Late Breaking Abstract: Alveolar epithelial function in mouse lungs: A novel real-time measurement of barrier properties Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Late Breaking Abstract - A multiomic micro- and macro-anatomical cell atlas of the human lungs and airways Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021 Late Breaking Abstract - Alveolar macrophages preferentially take up microvesicles in the alveolar space Source: International Congress 2017 – Novel mechanisms and therapeutic targets in lung injury and repair Year: 2017 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time. Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Estimation of alveolar surface area by functional morphometry utilising a premature baboon model Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021 Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Late Breaking Abstract - Management of COVID-19 pneumonia in an enhanced respiratory step down unit: a novel approach. Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Late Breaking Abstract - Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through systemic modulation of monocyte phenotypes Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS. Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients Year: 2018 Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 LSC Abstract - Differentiation between inflammation and hyperinflammation in the murine lung Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018 Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021